Indian Company to Develop the Dialysis Market in Kazakhstan
At the site of JSC "NC "KAZAKH INVEST, the Industry executive of the national company Dinara Isabekova, Project manager Madina Abdikadir, and the Director of the Planning and Forecasting department of the NAO "Social Health Insurance Fund" Marina Faleeva met with Vikram Vuppala, CEO of the Indian NephroPlus. During the meeting, the parties discussed the company's plans for developing the dialysis market in Kazakhstan.
Thus, Vikram Vuppala told the Kazakh representatives that NephroPlus considers Kazakhstan as a new market for investment in the framework of expanding its presence in Central Asia. Such an initiative provides for opening new dialysis centers, partnership with local medical institutions, professional development of medical personnel, and the introduction of advanced dialysis technologies.
In turn, representatives of KAZAKH INVEST told investors about the mechanisms and measures of state support, Kazakhstan's investment climate, and new promising areas in healthcare.
"We are confident that cooperation with international companies such as NephroPlus will help significantly improve the quality of medical services in the country. Kazakhstan is ready to provide all the necessary conditions for the successful implementation of this project," Dinara Isabekova stressed.
In conclusion, the parties agreed to cooperate in the implementation of future projects in this industry.
NephroPlus is Asia's largest network of dialysis centers, with more than 250 facilities in various Asian countries. The company provides high-quality dialysis services and offers a comprehensive approach to treating patients with chronic renal failure.
